Amelioration of SLE-like manifestations in (NZBxNZW)F1 mice following treatment with a peptide based on the complementarity determining region 1 of an autoantibody is associated with a down-regulation of apoptosis and of the pro-apoptotic factor JNK kinase-Reference-Cited by-同舟云学术

Amelioration of SLE-like manifestations in (NZBxNZW)F1 mice following treatment with a peptide based on the complementarity determining region 1 of an autoantibody is associated with a down-regulation of apoptosis and of the pro-apoptotic factor JNK kinase

Published:2005-12 Issue:3 Volume:117 Page:262-270
ISSN:1521-6616
Container-title:Clinical Immunology
language:en
Short-container-title:Clinical Immunology

Author:

Rapoport Micha J.,Sharabi Amir,Aharoni Dorit,Bloch Olga,Zinger Heidy,Dayan Molly,Mozes Edna

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference53 articles.

1. An overview of the pathogenesis of systemic lupus erythematosus;Hahn,1993

2. Murine models of lupus;Theofilopoulos,1992

3. Induction of a systemic lupus erythematosus-like disease in mice by a common human anti-DNA idiotype;Mendlovic;Proc. Natl. Acad. Sci. U. S. A.,1988

4. The role of the 16/6 idiotype network in the induction and manifestation of systemic lupus erythematosus;Waisman;Int. Immunol.,1993

5. The role of anti-idiotypic antibodies in the induction of experimental systemic lupus erythematosus in mice;Mendlovic;Eur. J. Immunol.,1989

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peptide-based immunotherapy in lupus: Where are we now?;Rheumatology and Immunology Research;2023-09-01

2. Autoantibodies in systemic lupus erythematosus: From immunopathology to therapeutic target;Journal of Autoimmunity;2022-10

3. Polygenic autoimmune disease risk alleles impacting B cell tolerance act in concert across shared molecular networks in mouse and in humans;Frontiers in Immunology;2022-08-24

4. The Therapeutic Strategies for SLE by Targeting Anti-dsDNA Antibodies;Clinical Reviews in Allergy & Immunology;2021-09-20

5. Glycol chitosan-based tacrolimus-loaded nanomicelle therapy ameliorates lupus nephritis;Journal of Nanobiotechnology;2021-04-17